Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(7):1075–1079. doi: 10.1038/bjc.1997.183

A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.

H V Thomas 1, T J Key 1, D S Allen 1, J W Moore 1, M Dowsett 1, I S Fentiman 1, D Y Wang 1
PMCID: PMC2222732  PMID: 9083346

Abstract

The associations between serum concentrations of oestradiol, progesterone, testosterone and sex hormone-binding globulin (SHBG) and risk of breast cancer in premenopausal women were investigated in a prospective study of breast cancer on the island of Guernsey. Sixty-two women diagnosed with breast cancer an average of 8 years subsequent to blood collection were matched for day of menstrual cycle, age and year of blood collection with 182 control subjects. Cases had a 12% higher mean oestradiol concentration over the whole menstrual cycle (P = 0.17) with a large difference at mid-cycle (75% higher, P = 0.04). Differences between cases and control subjects in progesterone (luteal phase), testosterone and SHBG were small and not statistically significant: luteal phase progesterone 9% lower in cases, P = 0.64; testosterone 4% higher, P = 0.57; SHBG 8% higher, P = 0.24. The small difference in oestradiol concentration could be aetiologically important, but larger prospective studies are needed.

Full text

PDF
1078

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein L., Yuan J. M., Ross R. K., Pike M. C., Hanisch R., Lobo R., Stanczyk F., Gao Y. T., Henderson B. E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control. 1990 Jul;1(1):51–58. doi: 10.1007/BF00053183. [DOI] [PubMed] [Google Scholar]
  2. Berrino F., Muti P., Micheli A., Bolelli G., Krogh V., Sciajno R., Pisani P., Panico S., Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996 Mar 6;88(5):291–296. doi: 10.1093/jnci/88.5.291. [DOI] [PubMed] [Google Scholar]
  3. Dorgan J. F., Longcope C., Stephenson H. E., Jr, Falk R. T., Miller R., Franz C., Kahle L., Campbell W. S., Tangrea J. A., Schatzkin A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):533–539. [PubMed] [Google Scholar]
  4. Hammond G. L., Langley M. S., Robinson P. A. A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG). J Steroid Biochem. 1985 Oct;23(4):451–460. doi: 10.1016/0022-4731(85)90192-x. [DOI] [PubMed] [Google Scholar]
  5. Helzlsouer K. J., Alberg A. J., Bush T. L., Longcope C., Gordon G. B., Comstock G. W. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994;18(2):79–85. [PubMed] [Google Scholar]
  6. Key T. J., Pike M. C., Moore J. W., Bulbrook R. D., Clark G. M., Allen D. S., Wang D. Y. The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. Contraception. 1989 Feb;39(2):179–186. doi: 10.1016/s0010-7824(89)80006-x. [DOI] [PubMed] [Google Scholar]
  7. Key T. J., Pike M. C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. doi: 10.1016/0277-5379(88)90173-3. [DOI] [PubMed] [Google Scholar]
  8. Key T. J., Wang D. Y., Brown J. B., Hermon C., Allen D. S., Moore J. W., Bulbrook R. D., Fentiman I. S., Pike M. C. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer. 1996 Jun;73(12):1615–1619. doi: 10.1038/bjc.1996.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Malarkey W. B., Schroeder L. L., Stevens V. C., James A. G., Lanese R. R. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res. 1977 Dec;37(12):4655–4659. [PubMed] [Google Scholar]
  10. Moore J. W., Clark G. M., Hoare S. A., Millis R. R., Hayward J. L., Quinlan M. K., Wang D. Y., Bulbrook R. D. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer. 1986 Nov 15;38(5):625–630. doi: 10.1002/ijc.2910380502. [DOI] [PubMed] [Google Scholar]
  11. Moore J. W., Key T. J., Bulbrook R. D., Clark G. M., Allen D. S., Wang D. Y., Pike M. C. Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer. 1987 Nov;56(5):661–666. doi: 10.1038/bjc.1987.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pike M. C., Spicer D. V., Dahmoush L., Press M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35. doi: 10.1093/oxfordjournals.epirev.a036102. [DOI] [PubMed] [Google Scholar]
  13. Rosenberg C. R., Pasternack B. S., Shore R. E., Koenig K. L., Toniolo P. G. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol. 1994 Sep 15;140(6):518–525. doi: 10.1093/oxfordjournals.aje.a117278. [DOI] [PubMed] [Google Scholar]
  14. Secreto G., Recchione C., Fariselli G., Di Pietro S. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res. 1984 Feb;44(2):841–844. [PubMed] [Google Scholar]
  15. Secreto G., Toniolo P., Pisani P., Recchione C., Cavalleri A., Fariselli G., Totis A., Di Pietro S., Berrino F. Androgens and breast cancer in premenopausal women. Cancer Res. 1989 Jan 15;49(2):471–476. [PubMed] [Google Scholar]
  16. Toniolo P. G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K. L., Shore R. E., Strax P., Pasternack B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995 Feb 1;87(3):190–197. doi: 10.1093/jnci/87.3.190. [DOI] [PubMed] [Google Scholar]
  17. Wysowski D. K., Comstock G. W., Helsing K. J., Lau H. L. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol. 1987 May;125(5):791–799. doi: 10.1093/oxfordjournals.aje.a114596. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES